Skip to main content
Explore URMC

menu

A Study of the Safety and Effectiveness of Apixaban in Preventing Blood Clots in Children With Leukemia Who Have a Central Venous Catheter and Are Treated With Asparaginase

Research Question:
Does the drug Apixaban prevent blood clots in children with leukemia or lymphoma?

Basic Study Information

Purpose:
The purpose of this study is to compare the effect of a blood thinning drug called Apixaban versus no administration of a blood thinning drug, in preventing blood clots in children with leukemia or lymphoma. Patients must be receiving chemotherapy, including asparaginase, and have a central line (a catheter inserted for administration of medications and blood sampling)

Location: University Of Rochester General Clinical Research Center

Study Contact Information

Study Coordinator: Angela Girvin, Site 0064
Phone: (585) 275-5839
Email: Clinical.Trials@bms.com

Additional Study Details

Contact This Study

This field is required
This field is required
You must agree to be contacted to continue.

Return to Search